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In the previous issue of Critical Care, Jackson and 
colleagues performed a systematic literature review with 
the goal of evaluating the impact of sedation prac  tices on 
the safety and economic outcomes in intensive care unit 
(ICU) patients [1]. Heterogeneity of the diﬀ  er  ent patient 
populations studied and variations in method  ology pre-
vented the authors from conducting a formal quantitative 
data synthesis and analysis; hence their article is primarily 
a collation of published studies. Th   e authors conclude that 
the past decade has seen much focus on sedation practices 
during critical illness and that a systematic approach to 
sedation and analgesia improves patient outcomes. Using 
the review as a springboard for our commentary, we would 
like to focus the reader towards an evidence-based 
paradigm for improving the quality of care and clinical 
outcomes of ventilated patients.
Over the past 15 years, we have learned in critical care 
that there are many potentially life-saving maneuvers we 
perform at the outset of a patient’s illness (for example, 
source control of infections, antibiotics, aggressive 
resusci  tation); we will refer to this as the front-end of 
critical care. It is now becoming imperative for us to 
improve our management of the back-end of critical care 
in order to optimize patients’ recovery and outcomes. We 
must therefore begin to focus on strategies to liberate our 
patients from life support that was instituted during the 
front-end period of high illness severity and then animate   
(get them out of the bed earlier) by focusing on ﬁ  ve 
evidence-based steps of care.  We refer to these steps as 
the ABCDE bundle (Awakening and Breathing Co  ordi-
nation of daily sedation and ventilator removal trials; 
Choice of sedative or analgesic exposure; Delirium moni-
tor  ing and management; and Early mobility and Exercise).
Critically ill patients are frequently prescribed sedatives 
and analgesics – especially if they are on mechanical 
ventilation (MV) – to ensure patient safety, to relieve 
pain and anxiety, to reduce stress and oxygen consump-
tion, and to prevent patient ventilator dysynchrony. 
Scientiﬁ   c advances in the past 10 to 15 years have 
revealed that these medications themselves contribute to 
increased morbidity, and perhaps even mortality [2-4]. 
Additionally a solid body of evidence demonstrates an 
independent association between commonly prescribed 
benzodiazepines and their attendant risk of delirium [2], 
and likewise the relationship between delirium and a 
dementia-like brain dysfunction following ICU care and 
mortality [5-7]. Th  ese observations have literally forced 
healthcare providers to study and determine best 
sedation practices to liberate patients faster from MV.
To fully understand ventilator liberation, one needs to 
review what happened to weaning during the 1990s. 
First, protocolization and daily spontaneous breathing 
trials were proven superior to the ongoing varied 
approaches to ventilator weaning [8]. Th  is was vitally 
important because of docu  mentation showing that about 
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Critically ill patients are frequently prescribed sedatives 
and analgesics to ensure patient safety, to relieve pain 
and anxiety, to reduce stress and oxygen consumption, 
and to prevent patient ventilator dysynchrony. 
Recent studies have revealed that these medications 
themselves contribute to worsening clinical outcomes. 
An evidence-based organizational approach referred 
to as the ABCDE bundle (Awakening and Breathing 
Coordination of daily sedation and ventilator removal 
trials; Choice of sedative or analgesic exposure; 
Delirium monitoring and management; and Early 
mobility and Exercise) is presented in this commentary.
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© 2010 BioMed Central Ltdtwo-thirds of the time on MV was spent during weaning, 
so anything that reduced this period would have a very 
high likelihood of improving outcomes. By the late 1990s 
and early 2000s, another body of literature was growing 
that showed continuous sedative infusions were 
associated with worse clinical outcomes and that 
protocolized, target-based sedation, with the 
incorporation of daily awaking trials (daily sedation 
cessation), resulted in decreased sedative exposure and 
shorter times on the ventilator [3,9].
Th  e next advance was bringing these two areas of 
weaning together for formal testing. Th   e Awakening and 
Breathing Controlled trial combined spontaneous awaken-
ing trials with spontaneous breathing trials (the ABCs of 
liberation from MV) and yielded a 4-day reduction in 
ICU and hospital lengths of stay and an unprecedented 
15% reduction in 1-year mortality [4]. Th   is study pointed 
to the importance of removing the silos of our care 
paradigms by centering the care delivered by nurses and 
respiratory therapists in an interdigitating protocol with 
checks and balances to improve patient safety and quality.
Liberation from MV is often hampered by non  pulmo-
nary organ dysfunction. In a subgroup analysis of the 
ARDSnet low versus high tidal volume study, it was noted 
that older survivors recovered from respiratory failure 
and achieved spontaneous breathing at the same rate as 
younger patients, but had greater diﬃ   culty  achieving 
liberation from the ventilator and successful ICU 
discharge [10]. Th   is study led to the hypothesis that older 
patients developed acute brain dysfunction (manifested 
as delirium and coma); but without validated tools to 
diagnose this dysfunction in the ICU, the hypothesis 
could not be tested.
Development of easy to use delirium monitoring instru-
ments such as the Confusion Assessment Method for the 
ICU [11] and the Intensive Care Delirium Screening 
Checklist [12] (the D of the ABCDEs) led to investigations 
that quantiﬁ  ed the undesirable consequences of delirium 
in the critically ill [5-7], and identiﬁ  ed  sedative 
medications (benzodiazepines in particular) as modiﬁ  able 
risk factors for delirium [2]. Psychoactive medications 
could for the ﬁ  rst time be compared using central nervous 
system outcomes (delirium). Th  e ensuing MENDS and 
SEDCOM studies compared benzodiazepines (GABAA-
agonists) versus dexmedetomidine (an α2-agonist) and 
showed that patients managed with the α2-agonist 
approach experienced a 20% or more reduction in the 
daily rates of delirium while on MV [13-15].
Th   e ability to monitor for delirium has also allowed us 
an opportunity to study analgosedation techniques that 
focus on treating pain ﬁ  rst and on utilizing the sedating 
properties of the analgesics, thus avoiding GABAA-
agonists. Such techniques have been associated with 
shorter times on MV and in the ICU [16], and may 
reduce the overall burden of delirium and its conse-
quences, given that pain itself predisposes patients to 
delirium. Clearly much works needs to be done in this 
area, as we determine best strategies to prevent and 
manage delirium.
Th   e last component of the ABCDE bundle is related to 
the need for early mobility and exercise (the E of the 
ABCDEs) to prevent and rehabilitate the muscles and 
nerves of the body experiencing the nearly universal 
problem of ICU-acquired weakness. Surely immobiliza-
tion and comatose states asso  ciated with heavy sedation 
and MV are contributors, yet some degree of this 
acquired disease process develops even without sedation 
and MV. It was only recently that Schweickert and 
colleagues incorporated an early physical therapy program 
in addition to daily sedation cessations, and demonstrated 
that patients who underwent early mobilization had a 
signiﬁ  cant improvement in functional status at hospital 
discharge [17]. Th  is study also showed that the early 
mobility group experienced roughly a 50% reduction in 
the duration of delirium in the ICU and hospital [17], 
supporting interconnectedness of the brain and body via 
the mantra that ‘exercise sparks the brain’.
Healthcare providers are thus encouraged to incor-
porate strategies that lead to early liberation and anima-
tion; the ABCDE bundle represents just one method of 
approaching the organizational changes that need to 
occur to eﬀ  ect a change of culture that will breed success. 
Persisting with our old approach to the back-end of care 
for these vulnerable patients is possible, but it is irres-
ponsible in light of the growing body of evidence that 
says we can do so much better for our patients. Given 
that there are negligible adverse consequences of imple-
menting these recommended strategies [4,9,17], minimal 
costs associated with changing commonly prescribed 
medications [14,18], and no evidence of adverse short or 
long-term psychiatric or neuropsychological eﬀ  ects  of 
minimizing sedation exposure [19,20], the pendulum 
needs to swing back to having interactive patients with 
well-controlled pain who can participate in physical and 
cognitive activities at the earliest possible safe point in 
their critical illness.
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